Reminder app for pulmonary hypertension inhaler
Part of Lungs & breathing clinical trials.
This study tests if a smartphone app can help people with pulmonary arterial hypertension (PAH) stick to their inhaled iloprost treatment. It is for adults already on this treatment at a specific clinic in Brazil.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with pulmonary arterial hypertension (PAH) through a heart catheterization test.
- Your mean pulmonary artery pressure is above 20 mmHg at rest.
- You have been using the inhaled medication iloprost.
- You are able to perform a 6-minute walk test.
- You have not had stomach or intestinal bleeding in the last 12 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether regular remote check-ins and guidance can help people with pulmonary arterial hypertension stick to their treatment plan. You would be followed by phone or video from University of Sao Paulo.
This trial tests a home-based exercise program delivered through a smartphone app for people with pulmonary arterial hypertension (PAH), a condition where the blood vessels in the lungs are narrowed, making the heart work harder. The program aims to improve physical function and quality of life through guided telerehabilitation.
This trial tests whether a smartphone app can help adolescents with pulmonary hypertension stay active and improve their health. If you are a teen with stable PH and can use an activity tracker, this study may be a good fit.
This study tests whether using a mobile health tool can help people with pulmonary arterial hypertension (PAH) manage their condition in daily life. It’s aimed at adults who are stable on their PAH medicines and can track activity using a wearable device.
This study tests whether a smartphone app called FORTISKAP helps people stick to their oral medications for lung conditions like interstitial lung disease and pulmonary hypertension. If you join, you'll either use the app or receive usual care, and the goal is to see if the app improves medication routines and outcomes.
This study tests a smartphone app that helps you learn or improve how to use your inhaler correctly. The app provides education and training to make sure you get the most from your medication.
Hear when a new Pulmonary Arterial Hypertension (PAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.